Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus‐prone mice

Abstract

Syk inhibition suppresses the development of lupus skin and kidney disease in lupus-prone mice, suppresses established disease in lupus-prone mice, and may represent a valuable treatment for patients with SLE.